PFE vs SMCI: Which Is the Better Buy?

Side-by-side comparison of Pfizer Inc. and Super Micro Computer, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-18.
Pfizer Inc. · Healthcare
$26.91
+30.1% upside to fair value
Med Conviction Grade B+
VS
Super Micro Computer, Inc. · Technology
$28.56
+435.6% upside to fair value
Grade B
QuantHub Verdict
SMCI has more upside to fair value (+435.6%). PFE trades at a lower forward P/E (9.5x). These are model outputs — not personalized investment advice. See all research →
Valuation & Fundamentals
Metric PFE SMCI
Current Price $26.91 $28.56
Fair Value Estimate $35.00 $152.97
Upside to Fair Value +30.1% +435.6%
Market Cap $153.0B $17.1B
Forward P/E 9.5x 19.5x
EV / EBITDA 13.8x 15.0x
Price / Sales 2.4x 0.6x
Price / FCF 16.8x 38.9x
Revenue Growth YoY -1.6% +152.8%
Gross Margin 70.3% 8.0%
Operating Margin 24.7% 3.7%
Return on Equity 9.0% 13.3%
Dividend Yield 6.4% 0%
FCF Yield 5.9% 2.57%
Analyst Consensus Hold Hold
Investment Thesis
PFE — Pfizer Inc.
Pfizer remains the world's largest traditional pharmaceutical company by non-COVID revenue, generating $62.6B in 2025 sales across oncology, cardiovascular, immunology, and vaccines. The stock trades at a P/S of 2.44x, still well below the 5-year median of 3.10x, driven by post-COVID revenue normalization, a $17-18B patent cliff spanning 2026-2028, and $61.6B in acquisition-related debt from Seag…
SMCI — Super Micro Computer, Inc.
Super Micro Computer, Inc. is a technology company specializing in server and storage systems with a dominant focus on AI GPU platforms that now drive over 70% of its revenues. The company benefits from a founder-led management team with deep industry expertise and long tenure, and it has scaled rapidly with revenue growth exceeding 150% year-over-year. Despite this explosive growth, profitabilit…
Accumulation Zones
Metric PFE SMCI
Zone Low $25.00 $114.73
Zone High $29.00 $130.02
In Buy Zone? Yes Yes
← PFE Research    SMCI Research →    All Research